Fifth Third Bancorp
MRNA icon

Fifth Third Bancorp’s Moderna MRNA Stock Holding History

Fifth Third Bancorp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.03M Sell
57,581
-2,760
-5% -$143K 0.01% 906
2026
Q1 		$3.07M Buy
60,341
+36,912
+158% +$1.72M 0.01% 996
2025
Q4 		$691K Sell
23,429
-8,659
-27% -$235K ﹤0.01% 689
2025
Q3 		$829K Buy
32,088
+11,108
+53% +$310K ﹤0.01% 685
2025
Q2 		$579K Buy
20,980
+6,830
+48% +$180K ﹤0.01% 722
2025
Q1 		$401K Buy
14,150
+6,889
+95% +$244K ﹤0.01% 802
2024
Q4 		$302K Sell
7,261
-59
-0.8% -$2.82K ﹤0.01% 873
2024
Q3 		$489K Sell
7,320
-3,858
-35% -$354K ﹤0.01% 787
2024
Q2 		$1.33M Buy
11,178
+1,842
+20% +$233K 0.01% 539
2024
Q1 		$995K Buy
9,336
+4,070
+77% +$410K ﹤0.01% 601
2023
Q4 		$524K Sell
5,266
-4,309
-45% -$362K ﹤0.01% 732
2023
Q3 		$989K Sell
9,575
-3,634
-28% -$405K ﹤0.01% 581
2023
Q2 		$1.6M Buy
13,209
+512
+4% +$68.3K 0.01% 490
2023
Q1 		$1.95M Sell
12,697
-850
-6% -$140K 0.01% 449
2022
Q4 		$2.43M Buy
13,547
+3,999
+42% +$654K 0.01% 418
2022
Q3 		$1.13M Buy
9,548
+1,286
+16% +$195K 0.01% 524
2022
Q2 		$1.18M Sell
8,262
-880
-10% -$126K 0.01% 521
2022
Q1 		$1.57M Buy
9,142
+2,976
+48% +$501K 0.01% 500
2021
Q4 		$1.57M Buy
6,166
+2,866
+87% +$838K 0.01% 516
2021
Q3 		$1.27M Buy
3,300
+2,423
+276% +$894K 0.01% 539
2021
Q2 		$206K Buy
877
+141
+19% +$25.2K ﹤0.01% 969
2021
Q1 		$96K Buy
736
+222
+43% +$32.2K ﹤0.01% 1164
2020
Q4 		$54K Sell
514
-14,260
-97% -$1.44M ﹤0.01% 1355
2020
Q3 		$1.04M Buy
14,774
+610
+4% +$42.5K 0.01% 517
2020
Q2 		$909K Sell
14,164
-1,235
-8% -$67.6K 0.01% 527
2020
Q1 		$461K Buy
+15,399
New +$354K ﹤0.01% 611

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fifth Third Bancorp's MRNA Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Moderna (MRNA) stake by 4.6% in Q2 2026, selling an estimated $143K and leaving 57,581 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #906.

Fifth Third Bancorp first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Fifth Third Bancorp held 57,581 shares of Moderna worth $4.03M as of Q2 2026.
  • Fifth Third Bancorp sold 2,760 Moderna shares in Q2 2026, an estimated $143K.
  • Moderna made up 0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #906 holding.
  • Fifth Third Bancorp first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.